Hydralazine Hydrochloride 20 mg / mL Injection 1 mL

NDC 00517-0901-25 is also written 00517090125. Reference details for licensed healthcare facility review and verification.

NDC 1100517-0901-25
Product NDC00517-0901
Generic Drug NameHydralazine Hydrochloride
Brand NameHydralazine Hydrochloride
ManufacturerAmerican Regent, Inc.
Strength20 mg / mL
Dosage FormInjection
Drug TypeIntramuscular; Intravenous
Package Quantity25 Vial, Single-Dose
Package Description25 VIAL, SINGLE-DOSE in 1 TRAY (0517-0901-25) / 1 mL in 1 VIAL, SINGLE-DOSE
Active IngredientsHydralazine Hydrochloride
Marketing CategoryANDA

Unless explicitly stated in writing, no direct affiliation, sponsorship, or endorsement by individual product manufacturers with Premium Rx National, LLC should be implied. All brand names, trade names, and trademarks are the property of their respective owners and are presented solely for accurate product identification and informational reference.

NDC snapshot

Hydralazine Hydrochloride 20 mg / mL Injection is tracked under NDC 00517-0901-25 and rolls up into product family 00517-0901. Use this page to review package-level identifiers before comparing related family pages or starting a quote review.

  • Package configuration: 25 Vial, Single-Dose.
  • Manufacturer: American Regent, Inc..
  • Dosage form: Injection.
  • Family size: 1 indexed presentation.

Official references

Use official labeling and directory references to confirm presentation details while your team reviews the PRN catalog entry and related sourcing paths.

Potential alternatives with matching presentation

Open the comparison hub or review package-level listings from 19 product-NDC families with matching normalized presentation details. Review each product detail page before treating any item as a true alternative.

View Potential Alternative HubhydrALAZINE Hydrochloride 20 mg / mL Injection 1 mL Vial23 package-level listings in the comparison hub.

Sample package-level pages in this comparison set

Drug Shortage Information

Shortage summary

Documented shortage listings have referenced this NDC twice since 2014, a repeat pattern that suggests elevated future supply risk.

Source: Public FDA drug shortage records accessed through FDA-owned openFDA drug shortages queries.

This section is intended to help healthcare teams review public shortage history and related availability references for this product. Supply conditions can change quickly across manufacturers, distributors, and care settings, and these references may not reflect the latest market status. Premium Rx National does not guarantee completeness or suitability for clinical, operational, or purchasing decisions. Please confirm current availability with FDA, manufacturers, and other authoritative sources before relying on this information.

Hydralazine Hydrochloride 20 mg / mL Injection 1 mL, NDC 00517-0901-25, is a American Regent, Inc. 20 mg / mL injection presentation packaged as 25 Vial, Single-Dose. Historical public shortage information is available for this product reference.

NDC search formats

  • Canonical NDC 11: 00517-0901-25
  • Digits-only NDC 11: 00517090125
  • Possible 10-digit display formats: 0517-0901-25 (0517090125), 00517-901-25 (0051790125)

Multiple 10-digit display-format aliases can map to the same stored 11-digit billing NDC, so these are shown as search aliases rather than a single asserted package format.

Helpful product links

  • Search by brand name: Hydralazine Hydrochloride
  • NDC 11: 00517-0901-25
  • Product family NDC: 00517-0901
  • VA classification code: CV490
  • VA classification code description: ANTIHYPERTENSIVES,OTHER
  • VUID: 4002638